Thermal‐Cascade Multifunctional Therapeutic Systems for Remotely Controlled Synergistic Treatment of Drug‐Resistant Bacterial Infections
Source abstract
Abstract
Abstract Antimicrobial therapy remains one of the major global challenges, particularly in the absence of effective treatment strategies for drug‐resistant bacteria. In this study, a comprehensive treatment approach is proposed for drug‐resistant bacterial wound infections based on the development of thermal‐cascade multifunctional therapeutic systems (MTSs), spanning from the design of functional nanoscale materials to macroscopic smart hydrogel. Within the MTSs, functional antibiotic‐loaded hybrid nanoclusters enable targeted therapeutic delivery and synergistic mild hyperthermia‐antibiotic treatment, strongly suppressing drug‐resistant bacteria while demonstrating excellent biocompatibility with normal cells and tissues. Furthermore, near‐infrared irradiation can trigger the photothermal effects of hybrid nanoclusters to induce gelation of thermal‐sensitive hydrogel, forming MTSs to serve as highly adaptable, drug‐enriched protective dressings for infected wounds. Both in vitro and in vivo results substantiate that MTSs enhance the bioavailability of therapeutic agents (including bacterial internalization and tissue penetration), exert synergistic effects to completely eradicate drug‐resistant bacteria, promoted wound healing and revascularization, and demonstrate excellent biocompatibility. This work offers an innovative demonstration to address drug‐resistant bacterial infections through the advancement of sophisticated material systems.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Inhalation and Respiratory Drug Delivery · Antimicrobial agents and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmacy College of Biology Hunan University Changsha Hunan 410082 P. R. China
State Key Laboratory of Chemo/Biosensing and Chemometrics Hunan University Changsha Hunan 410082 P. R. China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Hunan Province · National Postdoctoral Program for Innovative Talents · Key Research and Development Program of Hunan Province of China
References (46)
Show source-provided references
1. 10.1016/S0140-6736(21)02724-010.1016/S0140-6736(21)02724-0 ↗
2. World Health Organization Landscape of diagnostics against antibacterial resistance gaps and priorities 2019 https://www.who.int/publications/i/item/10665326480.
3. 10.1038/s41579-020-0420-110.1038/s41579-020-0420-1 ↗
4. 10.1038/s41579-022-00820-y10.1038/s41579-022-00820-y ↗
5. 10.1038/s41467-018-03447-x10.1038/s41467-018-03447-x ↗
6. 10.1038/s41564-019-0480-z10.1038/s41564-019-0480-z ↗
7. 10.1038/s41579-018-0141-x10.1038/s41579-018-0141-x ↗
8. 10.1016/j.mib.2020.05.01210.1016/j.mib.2020.05.012 ↗
9. 10.1126/science.135.3508.106710.1126/science.135.3508.1067 ↗
10. 10.1038/nchembio.191110.1038/nchembio.1911 ↗
11. 10.1038/nm114510.1038/nm1145 ↗
12. 10.1038/nrmicro146410.1038/nrmicro1464 ↗
13. 10.1016/j.jconrel.2020.08.05510.1016/j.jconrel.2020.08.055 ↗
14. 10.1039/D1CS00074H10.1039/D1CS00074H ↗
15. 10.1038/nrmicro199410.1038/nrmicro1994 ↗
16. 10.1038/s41565-021-00866-810.1038/s41565-021-00866-8 ↗
17. 10.1038/s41551-017-0187-510.1038/s41551-017-0187-5 ↗
18. 10.1038/s41467-019-12429-610.1038/s41467-019-12429-6 ↗
19. 10.1002/adfm.20200064410.1002/adfm.202000644 ↗
20. 10.1002/adfm.20200645310.1002/adfm.202006453 ↗
21. 10.1002/adfm.20210344210.1002/adfm.202103442 ↗
22. 10.1002/anie.20220079910.1002/anie.202200799 ↗
23. 10.1038/s41467-022-31479-x10.1038/s41467-022-31479-x ↗
24. 10.1002/adfm.20180596410.1002/adfm.201805964 ↗
25. 10.1002/adfm.20230515410.1002/adfm.202305154 ↗
26. 10.1002/adma.20230166410.1002/adma.202301664 ↗
27. 10.1080/02656736.2017.136917310.1080/02656736.2017.1369173 ↗
28. 10.1021/nn103575a10.1021/nn103575a ↗
29. 10.1039/C3BM60323G10.1039/C3BM60323G ↗
30. 10.1002/adfm.20170736010.1002/adfm.201707360 ↗
31. 10.1039/C8MH00694F10.1039/C8MH00694F ↗
32. 10.1021/nn503118f10.1021/nn503118f ↗
33. 10.1021/acsnano.3c0528810.1021/acsnano.3c05288 ↗
34. 10.1021/acsnano.6b0616110.1021/acsnano.6b06161 ↗
35. 10.1002/adma.20170724010.1002/adma.201707240 ↗
36. 10.1016/j.jconrel.2020.05.00710.1016/j.jconrel.2020.05.007 ↗
37. 10.1016/j.cclet.2021.09.04510.1016/j.cclet.2021.09.045 ↗
38. 10.1039/C5CC05331E10.1039/C5CC05331E ↗
39. 10.1016/j.colsurfb.2018.09.08110.1016/j.colsurfb.2018.09.081 ↗
40. 10.1039/C9CC07511A10.1039/C9CC07511A ↗
41. 10.1021/acs.biomac.1c0007710.1021/acs.biomac.1c00077 ↗
42. 10.1016/j.addr.2012.09.01210.1016/j.addr.2012.09.012 ↗
43. 10.3390/pharmaceutics1112067110.3390/pharmaceutics11120671 ↗
44. 10.1002/adfm.20190569710.1002/adfm.201905697 ↗
45. M.Weinstein J.Patel A.Bobenchik S.Campeau S.Cullen M.Galas H.Gold R.Humphries T.Kirn J. L.Ii M100 Performance Standards for Antimicrobial Susceptibility Testing A CLSI supplement for global application 2020 https://clsi.org/standards/products/microbiology/documents/m100/.
46. 10.1093/jac/dkn32110.1093/jac/dkn321 ↗